STAT+: Everyone agrees AI scribes are increasing health care costs. No one agrees what to do about it

To hear health systems tell the story, artificial intelligence tools like ambient scribes are helping not only reduce doctor burnout, but also increasing payments from insurers that haven’t been compensating them properly. But on insurer earnings calls, the payers position themselves as white knights sounding the alarm on providers using AI to raise health care costs to an unsustainable level.

However, at least behind closed doors, both sides appear to agree that AI scribes are driving up health care costs. 

“The investors, the health plans, and the providers, in private, were like, ‘OK, well, it’s quite clear scribes are increasing coding intensity. One hundred percent,’” said Caroline Pearson, executive director at the Peterson Health Technology Institute, describing a roundtable PHTI held earlier this year. The nonprofit institute, founded in 2023, evaluates the impact of new technologies on health care costs and quality.

Continue to STAT+ to read the full story…

Joint Statement: Disability rights in the trilogue negotiation of the Regulation on Protection of Adults

Joint Statement: Disability rights in the trilogue negotiation of the Regulation on Protection of Adults Brussels, Belgium – 8 April 2026 A group of equality organisations calls on the EU Institutions to ensure the EU’s Regulation on Protection of Adults protects the fundamental rights of persons with disabilities and older persons. The call is shared […]

The post Joint Statement: Disability rights in the trilogue negotiation of the Regulation on Protection of Adults appeared first on Mental Health Europe.

Judge refuses to block sending abortion pill by mail for now, but says FDA must finish review

A federal judge Tuesday refused to block filling prescriptions for the abortion pill mifepristone by mail across the U.S. — at least for now — in a setback to Louisiana’s effort to stifle groups that send it into states where abortion is banned.

U.S. District Judge David Joseph, who sits in Lafayette, Louisiana, ruled against Louisiana Attorney General Liz Murrill, who asked that U.S. Food and Drug Administration rules that allow mifepristone to be dispensed through the mail be paused while a challenge to those 2023 regulations moves through the courts.

Read the rest…